EcoR1 Capital’s Ascendis Pharma A/S ASND Stock Holding History

EcoR1 Capital’s Portfolio ASND Stock Details ASND Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2022 Q4	–	Sell	-27,208	Closed	-$2.81M	–	68
2022 Q3	$2.81M	Buy	+27,208	New	+$2.58M	0.08%	57
2019 Q2	–	Sell	-360,819	Closed	-$42.5M	–	43
2019 Q1	$42.5M	Sell	360,819 -318,927	-47%	-$27.9M	3.91%	10
2018 Q4	$42.6M	Sell	679,746 -407,511	-37%	-$25.6M	4.26%	7
2018 Q3	$77M	Sell	1,087,257 -376,810	-26%	-$25.9M	6.94%	4
2018 Q2	$97.4M	Sell	1,464,067 -358,508	-20%	-$23.6M	9.27%	4
2018 Q1	$119M	Sell	1,822,575 -285,025	-14%	-$16M	11.96%	2
2017 Q4	$84.4M	Hold	2,107,600	–	–	9.51%	5
2017 Q3	$76.4M	Buy	2,107,600 +625,000	+42%	+$17.9M	10.18%	4
2017 Q2	$41.2M	Buy	1,482,600 +456,900	+45%	+$12.1M	7.31%	6
2017 Q1	$28.7M	Buy	1,025,700 +50,000	+5%	+$1.26M	7.26%	5
2016 Q4	$19.7M	Buy	975,700 +756,500	+345%	+$15.1M	6.29%	5
2016 Q3	$4.41M	Buy	+219,200	New	+$3.62M	1.35%	21

Other funds holding ASND

RCM

RA Capital Management Boston, Massachusetts $11.5B AUM 168.77% 1-Year Est. Return

Artisan Partners Milwaukee, Wisconsin $63.1B AUM 35.51% 1-Year Est. Return

Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return

BBA

Baker Bros. Advisors New York $20B AUM 154.41% 1-Year Est. Return

T. Rowe Price Associates Baltimore, Maryland $999B AUM 46.22% 1-Year Est. Return

Janus Henderson Group London $209B AUM 37.72% 1-Year Est. Return

Westfield Capital Management Boston, Massachusetts $30.6B AUM 61.81% 1-Year Est. Return

ACA

Avoro Capital Advisors New York $11.1B AUM 207.82% 1-Year Est. Return

Wellington Management Group Boston, Massachusetts $580B AUM 38.23% 1-Year Est. Return

T. Rowe Price Investment Management Baltimore, Maryland $153B AUM 38.14% 1-Year Est. Return

EcoR1 Capital's ASND Position: Q4 2022 in Review

EcoR1 Capital sold out of Ascendis Pharma A/S (ASND) in Q4 2022, closing a stake of 27,208 shares — an estimated $2.81M sold.

EcoR1 Capital first reported a position in ASND in Q3 2016 and held it in 12 quarters. The position peaked at $119M in Q1 2018. 186 funds tracked by Wall St. Rank hold ASND as of Q4 2022.

EcoR1 Capital reported no remaining Ascendis Pharma A/S position as of Q4 2022 after selling out during the quarter.
EcoR1 Capital sold 27,208 Ascendis Pharma A/S shares in Q4 2022, an estimated $2.81M.
EcoR1 Capital first reported a position in Ascendis Pharma A/S in Q3 2016 and held it in 12 quarters.
EcoR1 Capital's Ascendis Pharma A/S position peaked at $119M in Q1 2018.
186 funds tracked by Wall St. Rank held Ascendis Pharma A/S as of Q4 2022.

Based on EcoR1 Capital's 13F filing for Q4 2022, filed 14 Feb 2023.